Phoenix Financial’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-12,353
| Closed | -$208K | – | 428 |
|
|
2021
Q3 | $208K | Sell |
12,353
-365,985
| -97% | -$6.16M | ﹤0.01% | 385 |
|
|
2021
Q2 | $5.78M | Sell |
378,338
-240,380
| -39% | -$3.67M | 0.11% | 139 |
|
|
2021
Q1 | $12M | Sell |
618,718
-200,964
| -25% | -$3.91M | 0.27% | 97 |
|
|
2020
Q4 | $14.8M | Sell |
819,682
-82,297
| -9% | -$1.48M | 0.4% | 87 |
|
|
2020
Q3 | $16.4M | Buy |
901,979
+4,515
| +0.5% | +$82.1K | 0.69% | 55 |
|
|
2020
Q2 | $22.3M | Buy |
897,464
+13,996
| +2% | +$347K | 0.94% | 38 |
|
|
2020
Q1 | $15.4M | Buy |
883,468
+48,729
| +6% | +$849K | 0.78% | 45 |
|
|
2019
Q4 | $27.7M | Buy |
834,739
+154,007
| +23% | +$5.1M | 1.16% | 29 |
|
|
2019
Q3 | $15.5M | Buy |
+680,732
| New | +$15.5M | 0.73% | 61 |
|